Citi Maintains a 'Buy' on Gilead Sciences (GILD); $5B Buyback Encouraging; Stock Is Undervalued Relative to Cash Flow
Tweet Send to a Friend
Citi maintains a 'Buy' rating on Gilead Sciences Inc (Nasdaq: GILD), price target $54.
Citi analyst says, "The $5B stock ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst says, "The $5B stock ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
